Gina Mazzariello, Chief Legal Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 30,000 shares at $8.34 ($246K) on 2025-08-13, disclosed to the SEC on 2025-08-14.
Scheduled sale ($246k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.07 | 15,000 | $121K | 49.2% |
| 2 | $8.34 | 15,000 | $125K | 50.8% |
| Total | $8.21 avg | 30,000 | $246K | 100% |
| Filing → |
| AMLX | SELL | 2026-03-04 | $99K | — | Filing → |
| AMLX | SELL | 2026-02-25 | $48K | — | Filing → |
| AMLX | SELL | 2026-02-04 | $51K | — | Filing → |